Neutrophil Elastase Inhibitors: A potential prophylactic treatment option for SARS-CoV-2-induced respiratory complications?

Detalles Bibliográficos
Autores principales: Mohamed, Mahmoud M. A., El-Shimy, Ismail Amr, Hadi, Muhammad Abdul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276973/
https://www.ncbi.nlm.nih.gov/pubmed/32513225
http://dx.doi.org/10.1186/s13054-020-03023-0
_version_ 1783543028350189568
author Mohamed, Mahmoud M. A.
El-Shimy, Ismail Amr
Hadi, Muhammad Abdul
author_facet Mohamed, Mahmoud M. A.
El-Shimy, Ismail Amr
Hadi, Muhammad Abdul
author_sort Mohamed, Mahmoud M. A.
collection PubMed
description
format Online
Article
Text
id pubmed-7276973
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72769732020-06-08 Neutrophil Elastase Inhibitors: A potential prophylactic treatment option for SARS-CoV-2-induced respiratory complications? Mohamed, Mahmoud M. A. El-Shimy, Ismail Amr Hadi, Muhammad Abdul Crit Care Editorial BioMed Central 2020-06-08 /pmc/articles/PMC7276973/ /pubmed/32513225 http://dx.doi.org/10.1186/s13054-020-03023-0 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Editorial
Mohamed, Mahmoud M. A.
El-Shimy, Ismail Amr
Hadi, Muhammad Abdul
Neutrophil Elastase Inhibitors: A potential prophylactic treatment option for SARS-CoV-2-induced respiratory complications?
title Neutrophil Elastase Inhibitors: A potential prophylactic treatment option for SARS-CoV-2-induced respiratory complications?
title_full Neutrophil Elastase Inhibitors: A potential prophylactic treatment option for SARS-CoV-2-induced respiratory complications?
title_fullStr Neutrophil Elastase Inhibitors: A potential prophylactic treatment option for SARS-CoV-2-induced respiratory complications?
title_full_unstemmed Neutrophil Elastase Inhibitors: A potential prophylactic treatment option for SARS-CoV-2-induced respiratory complications?
title_short Neutrophil Elastase Inhibitors: A potential prophylactic treatment option for SARS-CoV-2-induced respiratory complications?
title_sort neutrophil elastase inhibitors: a potential prophylactic treatment option for sars-cov-2-induced respiratory complications?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276973/
https://www.ncbi.nlm.nih.gov/pubmed/32513225
http://dx.doi.org/10.1186/s13054-020-03023-0
work_keys_str_mv AT mohamedmahmoudma neutrophilelastaseinhibitorsapotentialprophylactictreatmentoptionforsarscov2inducedrespiratorycomplications
AT elshimyismailamr neutrophilelastaseinhibitorsapotentialprophylactictreatmentoptionforsarscov2inducedrespiratorycomplications
AT hadimuhammadabdul neutrophilelastaseinhibitorsapotentialprophylactictreatmentoptionforsarscov2inducedrespiratorycomplications

Ejemplares similares